Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;33(7):1178-1181.
doi: 10.1002/mds.27420.

Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females

Danuta Z Loesch  1 , Flora Tassone  2 , George D Mellick  3 , Malcolm Horne  4 , Justin P Rubio  4   5 , Minh Q Bui  6 , David Francis  7 , Elsdon Storey  8
Affiliations

Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females

Danuta Z Loesch et al. Mov Disord. 2018 Jul.

Abstract

Background and Objective There is convincing evidence that small CGG expansion (41-54 repeats): FMR1 "gray zone" alleles (GZ) contribute to the risk of parkinsonism in males, but there is insufficient corresponding data in females. This study intends to fill this gap. Methods We screened whole-blood-derived DNA from a cohort of 601 females diagnosed with idiopathic PD, and from dry Guthrie blood spots from a local sample of 1,005 female newborns (population controls), for the size of the FMR1 CGG repeat using a PCR technique. Results We found a significant excess (8.2%) of GZ carriers compared with 5.2% in the control sample, with a P value of 0.009 for the difference in proportions. Conclusion FMR1 gray zone alleles are a significant risk factor for parkinsonism in females. These population data and occasional reports of FXTAS-like or parkinsonian manifestations in carriers suggest possible mechanisms whereby the effects of these alleles synergize with the existing pathologies underpinning parkinsonism. © 2018 International Parkinson and Movement Disorder Society.

Keywords: FMR1 gene; Parkinson's disease; carrier screening; grey zone alleles; increased risk.

PubMed Disclaimer

References

    1. Schapira A, Hartmann A, Agid Y. Parkinsonian Disorders in Clinical Practice. Oxford, UK: Wiley-Blackwell; 2009.
    1. Migdalska-Richards A, Schapira AHV. The relationship between glucocerebrosidase mutations and Parkinson disease. J Neurochem. 2016 Oct;139(Suppl 1):77–90. - PMC - PubMed
    1. Loesch DZ, Khaniani MS, Slater HR, et al. Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism. Clin Genet. 2009;76:471–6. - PMC - PubMed
    1. Loesch DZ, Tassone F, Lo J, et al. New evidence for, and challenges in, linking small CGG repeat expansion FMR1 alleles with Parkinson's disease. Clin Genet. 2013;84:382–385. - PubMed
    1. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease. A clinico-pathological study of 100 cases. JNNP. 1992;55:181–184. - PMC - PubMed

Publication types

Substances